Supplementation of the diet with the functional fiber PolyGlycoplex®is well tolerated by healthy subjects in a clinical trial

Table 2 Total, HDL and LDL cholesterol and triglyceride levels at baseline, V2 and V3 visits (N = 54)

		Fasting total cholesterol (mmol/l)		HDL cholesterol (mmol/l)		LDL cholesterol (mmol/l)		Fasting triglycerides (mmol/l)
		Control	PGX	Control	PGX	Control	PGX	Control	PGX
	N	27	27	27	27	27	27	27	27
Baseline	Mean	4.81	4.88	1.75	1.68	2.79	2.89	0.87	0.95
	SD	0.95	0.90	0.44	0.49	0.86	0.73	0.35	0.36
Visit 2	Mean	4.64	4.41	1.70	1.62	2.72	2.59	0.87	0.91
	SD	0.99	0.98	0.39	0.44	0.83	0.68	0.33	0.55
Change at V2 from baseline	Mean	-0.16	-0.47	-0.04	-0.05	-0.07	-0.30	0.00	-0.02
	SD	0.43	0.52	0.19	0.19	0.36	0.43	0.28	0.40
Visit 3	Mean	4.40	4.1	1.63	1.59	2.56	2.41	1.01	0.94
	SD	1.02	0.97	0.41	0.43	0.83	0.70	0.66	0.51
Change at V3 from baseline	Mean	-0.40	-0.70	-0.12	-0.08	-0.23	-0.48	0.14	0.01
	SD	0.53	0.42	0.23	0.21	0.45	0.39	0.58	0.40

ISSN: 1475-2891